These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20840012)

  • 21. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
    Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y
    Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
    Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC
    Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of density-dependent growth inhibition and dissociation of alpha-catenin from E-cadherin.
    Tsukatani Y; Suzuki K; Takahashi K
    J Cell Physiol; 1997 Oct; 173(1):54-63. PubMed ID: 9326449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs.
    Alves Pereira KM; do Amaral BA; dos Santos BR; Galvão HC; Freitas Rde A; de Souza LB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):425-31. PubMed ID: 20219600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
    Ramburan A; Hadley GP; Govender D
    Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interdependence of corticosterone and thyroid hormones in toad larvae (Bufo boreas). II. Regulation of corticosterone and thyroid hormones.
    Hayes TB; Wu TH
    J Exp Zool; 1995 Feb; 271(2):103-11. PubMed ID: 7884384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
    Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
    Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
    Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
    Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The E-cadherin complex contains the src substrate p120.
    Aghib DF; McCrea PD
    Exp Cell Res; 1995 May; 218(1):359-69. PubMed ID: 7537697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
    Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
    Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
    Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change in E-cadherin, alpha-, beta- and gamma-catenin expression after hyperthermia of a human colon carcinoma cell line in vitro].
    Liang H; Li JW; Shi YR; Niu RF; Wang P; Hao XS
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1299-303. PubMed ID: 15387970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.
    Nozawa N; Hashimoto S; Nakashima Y; Matsuo Y; Koga T; Sugio K; Niho Y; Harada M; Sueishi K
    Pathol Res Pract; 2006; 202(9):639-50. PubMed ID: 16843618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
    Zou W; Hu CH; Zhou JP
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations induced by E-cadherin and beta-catenin antibodies during the development of Bufo arenarum (Anura-Bufonidae).
    Izaguirre MF; Adur JF; Soler AP; Casco VH
    Histol Histopathol; 2001 Oct; 16(4):1097-106. PubMed ID: 11642730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial organization: new perspective on α-catenin from an ancient source.
    Reynolds AB
    Curr Biol; 2011 Jun; 21(11):R430-2. PubMed ID: 21640901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyaniline nanofibers: acute toxicity and teratogenic effect on Rhinella arenarum embryos.
    Yslas EI; Ibarra LE; Peralta DO; Barbero CA; Rivarola VA; Bertuzzi ML
    Chemosphere; 2012 Jun; 87(11):1374-80. PubMed ID: 22386461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An α-catenin déjà vu.
    Han SP; Yap AS
    Nat Cell Biol; 2013 Mar; 15(3):238-9. PubMed ID: 23449146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.